The Ethical Aspects of Transgenic Organisms - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

The Ethical Aspects of Transgenic Organisms

Description:

http://www.ananova.com/news/story/sm_279637.html. Cows ... ( http://www.nytimes.com/2003/01/21/national/27MILK.html?pagew...) Ethical Aspects ... – PowerPoint PPT presentation

Number of Views:47
Avg rating:3.0/5.0
Slides: 15
Provided by: dennis106
Category:

less

Transcript and Presenter's Notes

Title: The Ethical Aspects of Transgenic Organisms


1
The Ethical Aspects of Transgenic Organisms
  • Dennis Cooley
  • Department of History
  • North Dakota State University
  • Supported by a USDA/CSREES/IFAFS grant,
    Consortium to Address Social, Economic, and
    Ethical Aspects of Biotechnology.

2
Biotechnology Industry Statistics
  • There are 1,457 biotechnology companies in the
    United States, of which 342 are publicly held.
  • Market capitalization, the total value of
    publicly traded biotech companies at market
    prices, was 224 billion as of early May 2002.
  • The biotechnology industry has more than tripled
    in size since 1992, with revenues increasing from
    8 billion in 1992 to 27.6 billion in 2001.
  • The U.S. biotech industry spent 15.6 billion on
    research and development in 2001.
  • http//www.bio.org/er/statistics.asp

3
Antibiotics
  • New antibiotics through genetic modification
  • Many antibiotics that were once highly effective
    are now proving to be useless as the
    disease-causing microorganisms develop
    resistance.
  • Antibiotics and antibiotic resistanceAntibiotics
    are chemicals produced naturally by
    microorganisms in the environment that kill, or
    prevent the growth of other microorganisms.
  • New antibioticsA soil bacterium Streptomyces
    is a source of antibiotics, immunosuppressants,
    anti-cancer and anti-parasitic agents, and
    natural herbicides. It is possible to generate
    new compounds by changing the blueprint
    switching some of the genes, and thus some of the
    units, around.
  • http//www.jic.bbsrc.ac.uk/exhibitions/bio-future
    /medbiotech.htm

4
Environment
  • Transgenic foods such as canola, sugarbeets,
    soybeans and corn are already in the market.
    Hundreds of biopesticides and other agricultural
    products are being used to improve the food
    supply and to reduce our dependence on
    conventional chemical pesticides.
    http//www.bio.org/er/statistics.asp
  • Ready to enter the market Wheat in North Dakota

5
Pigs
  • Enzymes, such as amylases and proteases, are
    being added to animal feed to supplement the
    animals own enzymes and improve digestion. Most
    animal feedstuffs are plant-derived and contain
    anti-nutritional factors that interfere with
    digestion in a variety of ways. Many of these
    factors are non-starch polysaccharides, from
    cereal grains. Adding enzymes (beta-glucanases
    and arabinoxylanase) to feedstuffs increases the
    nutritional value of feeds by breaking down these
    factors, aiding digestion and making nutrients
    more easily absorbed. Phytic acid is another
    anti-nutritional compound found in plant cereals
    that prevents dietary absorption of essential
    minerals such as iron and zinc. It also pollutes
    the environment because it is excreted as
    phosphorus in manure. Addition of phytase in the
    diet helps digestion, but until it was recently
    cloned this enzyme was not available in
    sufficient quantities for widespread use.
  • Enviropigs
  • Each contains an enzyme in its saliva which
    helps digest food better and so creates less
    smell and pollution through its manure.
    http//www.ananova.com/news/story/sm_279637.html

6
Cows
  • New Zealands AgResearch, a government-owned
    research company, put extra copies of the genes
    for beta-casein and kappa-casein (milk proteins)
    into laboratory cow cells. The cells were
    cloned, and then implanted. Nine of the eleven
    cows born produce milk with 8 to 20 more beta
    casein and twice as much kappa casein.
  • The Food and Drug Administration has asked that
    milk or meat from cloned animals not be sold
    while it develops a policy on such products.
    (http//www.nytimes.com/2003/01/21/national/27MILK
    .html?pagew...)

7
Ethical Aspects
  • Is biotechnology morally good or bad?
  • Is working to create biotechnology morally right
    or wrong?
  • It depends.

8
Some Practical Ethical Theories
  • Reasonable Person Utilitarianism (Do the best you
    can.)
  • An act is morally right only if a reasonable
    person would reasonably believe that the utility
    of the consequences of the act will probably be
    as great as any alternative to the action at that
    time.
  • Quasi-Categorical Imperative (If you do not want
    it done to you, then do not do it to anyone else
    AND if it is wrong for everyone to do it, then it
    is wrong for you to do it)
  • An act is morally right only if in doing the
    act, the agent does not treat anyone as a mere
    means.

9
The Moral Saint Test
  • Think of an actual person who you who you would
    like to emulate.
  • Eliminate the persons vices.
  • In your mind, tell the person what you think is
    the correct solution to moral dilemma. The
    correct solution must be one that you would do if
    you were faced with the choice.
  • If your paradigm would not lose some respect for
    you, then you know that you probably have
    selected the correct solution.
  • If your paradigm would lose some respect for you,
    then you know that you probably have selected the
    wrong solution.

10
Applying the Theory
  1. Who is affected by the action?
  2. How are those people affected?
  3. Which alternative is likely to be the best?
  4. Are the mental states, including but not limited
    to intentions and motives, of the agent(s)
    performing the actions primarily good?

11
Applying the Theory
  • Golden Rice
  • Unethical.
  • RPU To a reasonable person, the outcome did not
    reasonably appear to be the best that could have
    been done.
  • QCI The desires of the individuals who were to
    benefit were not consulted.

12
Applying the Theory
  • Pharmaceutical companies now use genetic
    engineering to produce large quantities of
    insulin for diabetics around the world. The
    common Escherichia coli (E. coli) bacteria is
    used to produce insulin. Using recombinant DNA
    (glossary id 27) technology, the gene for
    producing insulin is inserted into the E. coli's
    genetic material. These genetically engineered
    bacteria are turned into tiny insulin producing
    factories. http//www3.iptv.org/exploremore/ge/use
    s/use2_medical.cfm

13
Applying the Theory
  • Artificial Insulin
  • - Ethical
  • - RPU Many people are benefited with none
    harmed.
  • - QCI No one is treated as a mere means.

14
The End.
  • Thank you.
Write a Comment
User Comments (0)
About PowerShow.com